Harishankar Natesan, PhD
About Harishankar Natesan, PhD
Harishankar Natesan, PhD, is a Sr. R&D Engineer at Boston Scientific with expertise in cryo and RF ablation technologies for cardiovascular diseases and cancer treatment.
Company
Harishankar Natesan, PhD, is currently employed at Boston Scientific as a Senior R&D Engineer. Based in Saint Paul, Minnesota, he has been with the company since 2019. Boston Scientific is renowned for developing medical devices used in various interventional medical specialties, making it a significant place for Harishankar to contribute his expertise in cardiovascular disease and cancer treatment technologies.
Previous Roles
Before joining Boston Scientific, Harishankar Natesan worked at BTG plc as a Senior Mechanical Engineer-R&D from 2017 to 2019 in Arden Hills. He also held a position as an Intern in Research and Development at AtriCure, Inc. in the Greater Minneapolis-St. Paul Area for seven months in 2017. In his early career, he was engaged at the University of Minnesota, serving as a Graduate Teaching Assistant from 2014 to 2016 and as a Research Assistant from 2012 to 2017 in the Bioheat and Mass Transfer Laboratory. Additionally, he interned at the Indian Institute of Science during the summer of 2010.
Education and Expertise
Harishankar Natesan earned his Doctor of Philosophy (Ph.D.) in Mechanical Engineering from the University of Minnesota, where he studied from 2012 to 2019. He completed his Bachelor of Engineering (BE) in Mechanical Engineering at PSG College of Technology between 2008 and 2012. His technical expertise includes advanced proficiency in cryo and RF ablation technologies for cardiovascular diseases and cancer treatment, performing Finite Element Analysis (FEA), and conducting Multiphysics simulations.
Technical Skills and Contributions
Harishankar Natesan possesses technical expertise in Nitinol Frame Design, which is critical for minimally invasive therapies. He is adept at generating new concepts through computational methods and rapid prototyping, followed by evaluation through bench and animal testing. Harishankar also engages with internal and external Key Opinion Leaders (KOLs) to identify unmet clinical needs, bolstering his contributions to the development of novel medical technologies.